Company OverviewMagicMed Industries
MagicMed Industries Inc. (CSE:MGMD) is a biotechnology company focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD. MagicMed’s molecular derivatives library, the Psybrary™, is intended to be an essential building block from which industry partners can develop new patented products.
Speaker Bio Dr. Joseph Tucker
CEO & Director
Enveric Biosciences
CEO & Director
Enveric Biosciences
Dr. Joseph Tucker is a seasoned executive who has built several publicly traded biotechnology companies. He has worked closely with the MagicMed Science team since 2013. As CEO of MagicMed Industries, Dr. Tucker focuses on partnership development, capital raising and the pursuit of a successful exit strategy.
